טוען...
Thrombocytopenia in patients with myelodysplastic syndromes
Thrombocytopenia, common in leukemias and myelodysplastic syndromes (MDS), is responsible for increased risk of bleeding and delay of therapy. Platelet transfusions, although effective in increasing platelet counts, are limited by supply, are associated with risks, and result in limited and transien...
שמור ב:
| הוצא לאור ב: | Semin Hematol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4428284/ https://ncbi.nlm.nih.gov/pubmed/20620439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2010.02.006 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|